» Articles » PMID: 32964318

Baseline Characteristics and Long-term Outcomes of Steroid-resistant Nephrotic Syndrome in Children: Impact of Initial Kidney Histology

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2020 Sep 23
PMID 32964318
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although many pediatric nephrologists consider focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) as separate clinical entities, whether the initial histology could affect clinical courses in children with steroid-resistant nephrotic syndrome (SRNS) suspected of having an immune-based etiology remains unknown, especially for long-term outcomes.

Methods: We retrospectively reviewed long-term outcomes (> 3 years; median follow-up, 9.1 years) of 21 children with initial SRNS (FSGS, N = 9; MCD, N = 12) who achieved complete remission with immunosuppressive agents, including cyclosporine.

Results: At NS onset, incidence of acute kidney injury (67% vs. 8%, P < 0.05) and proportion of patients with non-selective proteinuria (56% vs. 0%, P < 0.01) were significantly higher in the FSGS group than the MCD group. Furthermore, median days until complete remission after treatment was significantly longer in the FSGS group than the MCD group (116 days vs. 45 days, P < 0.001). Although subsequent biopsy histology of the 12 patients in the MCD group was still identical in all MCD, three of nine patients in the FSGS group were reclassified from FSGS to MCD at second biopsy. At last visit, all patients maintained complete remission, and none developed chronic kidney disease.

Conclusions: Initial presentation in the FSGS group was characterized by more severe clinical manifestations than the MCD group. If complete remission is achieved, FSGS and MCD in children with immune-mediated SRNS may constitute a single disease spectrum because the long-term outcomes are favorable, irrespective of initial histology.

Citing Articles

Efficacy of rituximab and risk factors for poor prognosis in patients with childhood-onset steroid-resistant nephrotic syndrome: a multicenter study.

Yokota S, Kamei K, Fujinaga S, Hamada R, Inaba A, Nishi K Pediatr Nephrol. 2024; 39(10):2979-2988.

PMID: 38834892 DOI: 10.1007/s00467-024-06422-5.


Adult survivors of childhood-onset steroid-dependent and steroid-resistant nephrotic syndrome treated with cyclosporine: a long-term single-center experience.

Takemasa Y, Fujinaga S, Nakagawa M, Sakuraya K, Hirano D Pediatr Nephrol. 2023; 39(2):473-482.

PMID: 37608237 DOI: 10.1007/s00467-023-06108-4.


Long-Term Outcome of Secondary Steroid-Resistant Nephrotic Syndrome in Chinese Children.

Ying D, Liu W, Chen L, Rong L, Lin Z, Wen S Kidney Int Rep. 2021; 6(8):2144-2150.

PMID: 34386663 PMC: 8343794. DOI: 10.1016/j.ekir.2021.05.001.